Search results
Tattoos Linked To 21% Higher Malignant Lymphoma Risk, New Study Says
Forbes· 2 days agoA study of people in Sweden found that those who had gotten tattoos were 21% more likely to have...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 17 hours agoIn one study, Pfizer's Seagen-acquired drug, Adcetris, reduced the risk of death by 37% for patients...
Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy
MedPage Today· 2 days agoLow-dose radiotherapy for a slow-growing stomach lymphoma achieved near-perfect disease control with...
Cancer Breakthrough: Scientists Discover Game-Changing New Type of T Cells
SciTechDaily· 1 day agoResearchers from the University of Houston identified CD8-fit T cells with high motility and serial...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 4 days agoThe findings include results from the Phase III TRANSFORM trial of Breyanzi as a second-line...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 6 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 3 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Halsey Details ‘Rocky Start’ in Recovery From Lupus, Rare T-Cell Disorder
Rolling Stone via Yahoo News· 2 days agoT-cell chronic lymphoproliferative disorders include Sezary syndrome, T-cell prolymphocytic...
Brighton Fringe Review: JOHN HINTON: WELL WELL WELL . . ., Komeida Studio
Broadway World· 3 days agoJohn Hinton: Well Well Well . . . is a musical show that has Hinton using songs and the story of his...
Circadian checkpoint - Nature Immunology
Nature· 5 days agoImmune cell function and responses to immune checkpoint blockade are affected by the time of day owing to circadian rhythms. Data now published in Cell ...
